CtDNA for Early Response Assessment in PCNSL Treated with 1st Line Curative Intent (NLG-PCNSL-01)

Clinical trial NCT06755619 · RECRUITING

Trial details

NCT number: NCT06755619
Sponsor: Nordic Lymphoma Group
Status: RECRUITING
Study type: OBSERVATIONAL

Primary Central Nervous System (CNS) Lymphoma

Start date: 2025-01-01
Primary completion: 2030-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.